Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer†

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|16|3|222-231

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.16, Iss.3, 2016-03, pp. : 222-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Signal Transduction from Receptors of Type I and Type II Cytokines

By Fujii Hodaka  

Journal of Immunotoxicology, Vol. 4, Iss. 1, 2007-01 ,pp. : 69-76

Informa Healthcare

Access to resources Recommend Favorite

Expression of Transforming Growth Factor- Type I and Type II Receptors Is Altered in Rat Lungs Undergoing Bleomycin-Induced Pulmonary Fibrosis

By Zhao Y.   Shah D.U.  

Experimental and Molecular Pathology, Vol. 69, Iss. 2, 2000-10 ,pp. : 67-78

Elsevier

Access to resources Recommend Favorite

Differential regulation of NK cell proliferation by type I and type II IFN

By Loza Matthew J.   Perussia Bice  

International Immunology, Vol. 16, Iss. 1, 2004-01 ,pp. : 23-32

Oxford University Press

Access to resources Recommend Favorite

Molecular Phylogeny within Type I Cytokines and Their Cognate Receptors

By Boulay J.-L.   O'Shea J.J.   Paul W.E.  

Immunity, Vol. 19, Iss. 2, 2003-08 ,pp. : 159-163

Elsevier

Access to resources Recommend Favorite

Effect of a Hybrid Peptide Derived from Platelet Type I and Type III Collagen Receptors on CHO-65 Cells

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 9, Iss. 3, 2009-09 ,pp. : 167-171

Bentham Science Publishers

Access to resources Recommend Favorite